e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
ME12 Immunotherapies for lung cancer
Source:
Paris 2018 - Educational material
Number:
50
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
ME12 Immunotherapies for lung cancer. Paris 2018 - Educational material
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Immunotherapies for lung cancer
Source: International Congress 2018 – ME12 Immunotherapies for lung cancer FULLY BOOKED
Year: 2018
Aerosoltherapy in lung cancer
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008
Venothromboembolism in lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 601s
Year: 2007
Epigenetics and lung cancer
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006
Boosting immunotherapy in lung cancer
Source: International Congress 2017 – ME9 Boosting immunotherapy in lung cancer
Year: 2017
Lung cancer immunotherapy
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018
Nonsmall cell lung cancer
Source: Annual Congress 2012 - Maurizio Vignola Award for Innovation in Pneumology Ceremony (supported by Chiesi Foundation) followed by Clinical Year in Review I
Year: 2012
ME9 Boosting immunotherapy in lung cancer
Source: Milan 2017 - Educational material
Year: 2017
Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm
Source: Eur Respir J, 55 (2) 1901907; 10.1183/13993003.01907-2019
Year: 2020
New chemotherapeutic agents
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=259
Year: 2001
Update on nonsmall cell lung cancer
Source: Eur Respir Rev 2010 19: 173-185
Year: 2010
Biological therapies in nonsmall cell lung cancer
Source: Eur Respir J , 49 (3) 1601520; DOI: 10.1183/13993003.01520-2016
Year: 2017
Re-challenge of immunotherapy in a lung cancer patient
Source: Virtual Congress 2021 – Lung cancer grand round
Year: 2021
Lung cancer
Source: Respipedia Article
Year: 2018
Screening for lung cancer
Source: International Congress 2017 – Lung cancer for the pulmonologist
Year: 2017
How to handle oligometastatic disease in nonsmall cell lung cancer
Source: Eur Respir Rev, 30 (159) 200234; 10.1183/16000617.0234-2020
Year: 2021
Non-small cell lung cancer in never-smokers
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept